{"title": "Hearing on Drug Development and Approval", "author": null, "url": null, "hostname": null, "description": "The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration's (FDA) drug development and approval process. Dr. Janet Woodcock, the FDA witness in the first panel, said the agency speeds things up where it safely can but stressed that with some diseases speed was a challenge. Witnesses in the second panel of pharmaceutical and medical organization officials focused on how patients on certain drugs or clinical trials can be beneficial to the drug development and approval process in regard to making the process faster.", "sitename": "C-SPAN.org", "date": "2014-07-11", "cleaned_text": "Foundation Drug Development and Approval The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration's (FDA) drug... [read more ](#) The House Energy and Commerce Subcommittee on Health held a hearing on ways to expedite the Food and Drug Administration's (FDA) drug development and approval process. Dr. [Janet Woodcock](//www.c-span.org/person/?janetwoodcock), the FDA witness in the first panel, said the agency speeds things up where it safely can but stressed that with some diseases speed was a challenge. Witnesses in the second panel of pharmaceutical and medical organization officials focused on how patients on certain drugs or clinical trials can be beneficial to the drug development and approval process in regard to making the process faster. [close ](#) [Report Video Issue](#) [Go to Live Event](//www.c-span.org/event/?320394/hearing-drug-development-approval) this video - - [Gus Bilirakis](//www.c-span.org/person/?1022873)U.S. Representative [R] Florida - [Marsha Engel](//www.c-span.org/person/?6109)U.S. Representative New York Jersey - [Leonard Lichtenfeld M.D.](//www.c-span.org/person/?75805)Deputy Chief Medical Officer American Cancer Society Representative [R] Pennsylvania - [Marshall Summar Rare Diseases->Scientific Advisory Waxman](//www.c-span.org/person/?8319)U.S. Representative [D] California - [Janet Woodcock M.D.](//www.c-span.org/person/?37978)Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research [More People](#) Hosting Organization [House Energy and Commerce Subcommittee on Health](//www.c-span.org/organization/?61320)House Energy and Commerce Subcommittee on Health Related Video - Antibiotic Resistance and Drug Development Dr. Janet Woodcock testified at a House Energy and Commerce subcommittee hearing on combating antibiotic resistance and... - Medicare Prescription Drug Program Two Health and Human Services Department officials testified on reducing fraud and abuse in the Medicare Part D... - Fentanyl Addiction and Opioid Abuse Federal officials and medical professionals testified on the opioid epidemic and the federal response to the drug... - Opioid Epidemic State officials from Maryland, Virginia, Kentucky, and Rhode Island testified about the nation's opioid epidemic. The... "}